While North America has historically dominated the biotech landscape, a shift is occurring as new specialized clusters emerge globally. Analysis of the Cell and Gene Therapy CDMO Market region suggests that the Asia-Pacific area, particularly China and Singapore, is investing heavily in genomic infrastructure. These regions offer competitive labor costs and rapidly evolving regulatory...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt